Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
Official title: Association Between Serum Asprosin Concentration and Expression of Selected miRNAs With Risk Factors and Components of Metabolic Syndrome in Young Women: Diagnostic Perspectives
Run by University of Applied Sciences in Nowy Targ · NCT07917364 · Data updated 2026-11-12
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 35 Years |
| Sex | Women only |
| Enrollment | 110 (estimated) |
| Sponsor | University of Applied Sciences in Nowy Targ Academic / other |
| Locations | 1 site (Nowy Targ, Lesser Poland Voivodeship) |
| Status | Recruiting |
| Started | November 2026 |
| Main results expected | March 2027 |
| Study ends | March 2027 |
| Registry record updated | November 4, 2026 |
| Trial ID | NCT07917364 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Young women aged 18–35 who meet or do not meet NCEP ATP III criteria for metabolic syndrome, respectively, with no competitive sports participation or smoking.
✕Probably not a fit
Individuals outside the age range or with irregular cycles, pregnancy, current smoking, alcohol abuse, hormonal contraception use, or certain medications may not experience any direct benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational, cross-sectional case-control study enrolling young women aged 18 to 35. Researchers will measure serum asprosin concentration, six circulating microRNAs, and various metabolic and lifestyle factors from a single study visit. The goal is to see if the biomarker panel can distinguish those with metabolic syndrome from healthy controls and to explore relationships with components such as obesity, insulin resistance, and dyslipidemia. Secondary goals include comparing body composition, insulin resistance indices, lipid profiles, physical activity, diet, sleep quality, stress, and quality of life between groups. The study uses biomarker assays and questionnaire-based assessments to analyze potential diagnostic value and associations with metabolic risk factors.
Why it matters
Potential benefit: If successful, the biomarker panel could help identify metabolic risk earlier in young women and guide personalized prevention strategies.
How similar studies have gone: Previous research has shown promise for circulating microRNAs and adipokines as biomarkers in metabolic conditions, but results are heterogeneous and further validation is needed in young women.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female sex * Age 18 to 35 years * Regular menstrual cycle * Not engaged in competitive sports training in any discipline * Non-smoker * No alcohol abuse * No continuous pharmacotherapy, with the exception of treatment for diabetes and/or antihypertensive treatment; no use of hormonal contraception * Written informed consent for study participation and processing of personal data Exclusion Criteria: * Age outside the range of 18 to 35 years * Irregular menstrual cycle * Pregnancy or breastfeeding * Continuous pharmacotherapy for indications other than diabetes and/or hypertension, including any form of hormonal contraception (oral, transdermal, vaginal, implant, injectable or intrauterine) * Competitive sports training in any discipline * Current smoking * Alcohol abuse * Lack of written informed consent for study participation and processing of personal data
Where it's running
-
Institute of Medicine, University of Applied Sciences in Nowy Targ, Kokoszków 71, 34-400 Nowy Targ, Poland
Nowy Targ, Lesser Poland Voivodeship, Poland Recruiting
Study contacts
- Principal investigator: Małgorzata Kantorowicz, Ph. D. — University of Applied Sciences in Nowy Targ
- Study coordinator: Małgorzata Kantorowicz, Ph.D.
- Email: sknmedicus@ans-nt.edu.pl
- Phone: +48 662 251 012
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Kodo Millet Porridge and Gut Health in Overweight and Obese Adults
This study tests whether daily intake of Kodo millet porridge for 12 weeks can improve gut bacteria and metabolic health in adults who are overweight or obese.
-
Cranberry for gut and metabolic health in adults with overweight or obesity
This study will test whether drinking a cranberry beverage can improve blood sugar control, insulin sensitivity, blood lipids, and gut microbiota in adults with overweight or obesity who have metabolic risk factors.
-
Photoacoustic and ultrasound imaging of brown fat activity
This project will test a radiation-free photoacoustic and ultrasound scan to see if it can measure brown fat activity in healthy adults and people with metabolic syndrome.
-
Integrated Traditional Chinese Medicine Program for Metabolic Syndrome
This study is testing a combined approach of Chinese herbal medicine and laser acupuncture to see if it can help people with metabolic syndrome improve their health over six months.
-
Investigating body fat distribution and its impact on metabolic diseases in Japanese adults
This study looks at how the way body fat is distributed affects the risk of metabolic and heart diseases in Japanese adults.
-
Investigating fasting insulin and insulin resistance across different demographics
This study looks at how fasting insulin levels and insulin resistance vary among different groups of people based on age, sex, race, weight, and conditions like PCOS to better understand metabolic health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.